332
A variety of movement disorders are known to occur in association with carbamazepine (CBZ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
 adults and children: Subject; adults: Subject.Age; children: Subject.Age; movement disorders: Effect; carbamazepine (CBZ) therapy: Treatment; carbamazepine: Treatment.Drug; Tourette's syndrome: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 adults and children: Subject; adults: Subject.Age; children: Subject.Age; movement disorders: Effect; carbamazepine (CBZ) therapy: Treatment; carbamazepine: Treatment.Drug; Tourette's syndrome: Treatment.Disorder